Kinchak Pharmaceuticals-B (02595.HK): Hong Kong public offering received 2662.79 times oversubscription, global offering raised approximately HKD 1.67 billion.

Zhifubao Financial News App reports that Kingston Pharmaceuticals-B (02595.HK) has announced the results of its distribution. The company has globally issued 89.24 million shares, with 8.7% for public offering in Hong Kong and 91.3% for international offering. The issuance price per share is HK$20.39, with a net fundraising of approximately HK$1.67 billion globally. Each board lot consists of 200 shares, and it is expected that H shares will begin trading on the Stock Exchange on the morning of September 19, 2025 (Friday) at 9:00am.